The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended new measures to reduce the risk of dosing errors with medicines containing methotrexate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback